期刊文献+

TGF-β和P53蛋白在前列腺癌组织中的表达及其意义 被引量:4

Expressions of P53 and TGF-β in prostatic carcinoma tissue and their significances
下载PDF
导出
摘要 目的:探讨转化生长因子-β(TGF-β)和P53蛋白在前列腺癌组织中的表达及其临床意义。方法:应用免疫组织化学SP法检测36例前列腺癌标本组织中TGF-β和P53蛋白表达情况。结果:36例前列腺癌标本组织中高、中、低分化癌分别为10、16和10例。TGF-β在高、中和低分化前列腺癌组织中的阳性表达率分别为30%(3/10)、37.5%(6/16)和70.0%(7/10);P53蛋白在高、中和低分化前列腺癌组织中的阳性表达率分别为20%(2/10)、25.0%(4/16)和50%(5/10)。TGF-β和P53蛋白在高、中分化前列腺癌组织中的表达强度均低于在低分化前列腺癌组织(P<0.05)。结论:TGF-β和P53蛋白阳性表达率和表达强度与前列腺癌分化程度有相反的变化趋势,提示检测TGF-β与P53蛋白的表达可协助鉴定前列腺癌分化程度并评估预后。 Objective To study the expressions of TGF-β and P53 protein in prostatic carcinoma tissue and their clinical significances.Methods Immunohistochemical method was used to detect the expressions of TGF-β and P53 protein in 36 cases of prostatic carcinoma.Results 36 cases of prostatic carcinoma included 10 cases of well differentiation,16 cases of moderate differentiation,10 cases of poor differentiation.The positive expression rates of TGF-β in well,moderately,poorly differented prostatic carcinoma tissues were 30%(3/10),37.5%(6/16),and 70%(7/10);the positive expression rates of P53 protein in well,moderately,poorly differented prostatic carcinoma tissues were 20%(2/10),25%(4/16),and 50%(5/10).The expression rates of TGF-β and P53 protein in well and moderately differented prostatic carcinoma tissues were lower than those in poorly differented prostatic carcinoma tissues(P〈0.05).Conclusion The expressions of TGF-β and P53 have a negative correlation with the differented degree of prostatic carcinoma and the expressions of TGF-β and P53 may help to judge the pathologic grade and predict the prognosis of prostatic carcinoma.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2010年第2期364-367,I0006,共5页 Journal of Jilin University:Medicine Edition
基金 国家科学技术部国际科技合作重点项目资助课题(2004DFB02000)
关键词 前列腺肿瘤 转化生长因子-Β P53蛋白 免疫组织化学 prostatic neoplasms transforming growth factor-β P53 protein immunohistochemistry
  • 相关文献

参考文献10

  • 1Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer [ J]. Biochim Biophys Acta, 2007, 1775 (1): 21-62.
  • 2Kappler M, Taubert H, Bartel F, et al. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a rot-p53 sarcoma cell line [J]. Oncol Repa, 2005, 13 (1): 167-172.
  • 3王尧,王伟华,计国义,范海涛.吉林地区超声引导经直肠前列腺活检513例报告[J].中国老年学杂志,2008,28(19):1926-1927. 被引量:3
  • 4李泽良,杨野,李振华,孔垂泽.前列腺癌组织中TGF-β1 mRNA表达及其临床意义[J].中华男科学杂志,2005,11(7):511-513. 被引量:5
  • 5Cardillo MR, Petrangeli E, Perracchio L, et al. Transforming growth factor-beta expression in prostate neoplasia [J]. Anal Quant Cytol Histol, 2000, 22 (1): 1- 10.
  • 6Stravodimos K, Constantinides C, Manousakas T, et al. Immunohistochemical expression of transforming growth factor beta-1 and nm-23H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters [J]. AnticancerRes, 2000, 20 (5C): 3823-3828.
  • 7Ostrakhovitch EA, Olsson PE, Jiang S, et al. Interaction of metallothionein with tumor suppressor p53 protein [J ]. FEBSLett, 2006, 580 (5):1235-1238.
  • 8Che M, DeSilvio M, Pollack A, et al. Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: A study based on RTOG 9202 [J]. Rad Oncol Biol Phys, 2007, 69 (4): 1117-1123.
  • 9Oxley JD, Winkler MH, Parry K, et al. p53 and bcl-2 immunohistochemistry in preoperative biopsies as predictors of biochemical recurrence after radical postatectomy [J]. BJU Int, 2002, 89 (1): 27-32.
  • 10Rege YD, Rangnekar VM. Molecular therapy intervention prospects in prostate cancer [J]. Curr Pharm Des, 2004, 10 (5): 523-530.

二级参考文献21

  • 1王健,江怡,唐崎,顾炯,刘定益,祝宇,张羽中宇,王名伟.超声引导经直肠前列腺穿刺活检术(附192例报告)[J].中国男科学杂志,2005,19(2):31-33. 被引量:16
  • 2Ilio KY, Sensibar JA, Lee C. Effect of TGF-betal, TGF-alpha and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture[J]. J Androl, 1995, 16(6): 482-490.
  • 3Wilding G. Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta [ J ]. Cancer Surv, 1991,11: 147-163.
  • 4Pasche B. Role of transforming growth factor beta in cancer[ J ]. J Cell Physiol, 2001, 186(2): 153-168.
  • 5Bronzert DA, Bates SE, Sheridan JP, et al. Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells[J]. Mol Endocrinol, 1990, 4(7): 981-989.
  • 6Derynck R, Feng XH. TGF-beta receptor signaling[ J]. Biochim Biophys Acta, 1997, 1333(2): F105-F150.
  • 7Martikainen P, Kyprianou N, Isaacs JT, et al. Effect of transforming growth factor-betal on proliferation and death of rat prostatic cells[ J]. Endocrinology, 1990, 127 (6): 2963-2968.
  • 8Wikstrom P, Damber J, Bergh A. Role of transforming growth factor-betal in prostate cancer [ J]. Microsc Res Tech, 2001,52(4): 411-419.
  • 9Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-beta receptor [ J ]. Nature, 1994, 370 (6488): 341-347.
  • 10Massague J, Chen YG. Controlling TGF-beta signaling[J]. Genes Dev, 2000, 14(6): 627-644.

共引文献6

同被引文献54

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部